Intel, Oracle and CoreWeave Are All Selling Off — Can These AI Stocks Recover?
Three of the more closely watched names in the AI trade — Intel (INTC), Oracle (ORCL), and CoreWeave (CRWV) — have all pulled back sharply from recent highs over the past month, even as the broader market has mostly held up. Each stock has its own specific catalyst, but the common thread is familiar: high-multiple, capital-intensive AI plays getting hit as investors question whether record capital spending on AI infrastructure can keep paying off, against a backdrop of a more hawkish Federal Reserve. Here’s what’s driving each decline, and what history and the charts suggest about whether a recovery is likely.
Intel: A Wild Round Trip
Intel has had the most dramatic ride of the three. The stock surged more than 350% off its 52-week low of $18.97 to an all-time high of $142.35 on June 30, powered by a turnaround narrative built around Apple foundry chatter, progress on the 18A-P manufacturing node entering risk production, and growing speculation about U.S. government backing for the company’s foundry ambitions. Since then, Intel has pulled back to around $108–$112, caught up in a broader semiconductor selloff driven by Meta’s plans to monetize excess AI computing capacity and a hawkish dot plot from new Fed Chair Kevin Warsh that spooked rate-sensitive growth names.
What’s notable is the split in sell-side reaction. Even as the stock pulled back, several analysts have kept raising targets — KeyBanc to $155, HSBC to as high as $200, UBS to $121, TD Cowen to $115 — pointing to foundry momentum and AI server demand. Yet the broader analyst consensus is still just “Hold,” with an average target in the $87–$105 range, well below the current price. That’s an unusual setup: bulls are getting louder even as the average rating hasn’t caught up, and several prominent voices have warned the re-rating has run ahead of the fundamentals. Technically, Intel is still trading above its 200-day moving average and hasn’t broken its post-rally uptrend, which is a constructive sign — but the stock’s next real test is its Q2 2026 earnings report on July 23.
Oracle: The OpenAI Concentration Question
Oracle’s pullback looks different. The stock fell as much as 28–35% over a roughly one-month stretch, touching a fresh 52-week low near $132, after S&P Global flagged concerns about Oracle’s revenue concentration tied to OpenAI and projected a roughly $42 billion free-cash-flow deficit for fiscal 2027 as the company ramps up borrowing to fund its cloud buildout. Insider selling by Vice Chairman Jeffrey Henley in the $156–$165 range didn’t help sentiment either. For more background on Oracle’s underlying business, see our Oracle (ORCL) fact sheet.
The bull case, though, still has real substance: Oracle’s remaining performance obligations stand at $638 billion, up 363% year-over-year, and management has guided to $90 billion in fiscal 2027 revenue with raised non-GAAP EPS guidance of $8.05. Of the analysts covering the stock, 37 rate it Buy against just 1 Sell, and the average price target near $251.85 implies substantial upside from recent lows. The dividing line among AI-cloud names has been capital intensity: profitable, backlog-rich Oracle has still been punished more than debt-light SaaS peers like Cloudflare and Snowflake, which is a sign this decline is more about credit and cash-flow optics than demand.
CoreWeave: The Highest-Beta Name of the Three
CoreWeave’s decline has been the sharpest in percentage terms. The stock is down roughly 46% over the past year and shed as much as 30%+ in a single month, falling from an all-time high near $187 to around $80–$90 recently. The proximate catalyst was a Bloomberg report that Meta is exploring a “neocloud” business to resell its own excess AI computing capacity — a direct competitive threat to CoreWeave’s core model. That was compounded by a securities fraud class-action lawsuit filed in late June alleging the company understated its reliance on a single data-center supplier, plus a steady drumbeat of insider selling by CEO Michael Intrator (more than $30 million in stock sold this month alone) and a heavily leveraged balance sheet, with total liabilities near $50.8 billion. See our CoreWeave (CRWV) fact sheet for more detail.
On the other side of the ledger, CoreWeave’s backlog has kept growing — nearly $100 billion as of Q1 2026 — and Nvidia has taken a direct equity stake in the company. Ark Invest’s Cathie Wood has been buying the dip in recent weeks, and sell-side firms including Wolfe Research ($150 target) and Cantor Fitzgerald ($167 target) have reiterated bullish ratings through the selloff, with the average analyst price target sitting well above the current share price. CoreWeave is also the most volatile of the three names by a wide margin, with a beta above 2.8 — meaning both the drawdown and any recovery are likely to be larger and faster than for Intel or Oracle.
How This Compares to Past AI-Stock Selloffs
This isn’t the first time high-multiple AI infrastructure names have taken a sharp leg down on sentiment rather than a fundamental demand problem — prior corrections tied to efficiency scares and tariff headlines followed a similar pattern: a fast, sentiment-driven drawdown, followed by a recovery once the underlying growth and backlog numbers were reaffirmed in the next earnings report. The common thread across all three names today is that none of the selloffs were triggered by evidence of weaker AI demand itself — they were driven by competitive threats (Meta), balance-sheet and concentration concerns (Oracle), and litigation plus leverage worries (CoreWeave), layered on top of a market-wide reassessment of how much further AI capital spending can run. That distinction matters: corrections rooted in positioning and sentiment have historically been more prone to sharp recoveries than ones rooted in a genuine deterioration of the growth story, though there’s no guarantee that pattern repeats.
What the Charts Suggest
Technically, the three stocks are in different spots. Intel remains above its 200-day moving average and within its post-rally uptrend, which is generally read as constructive, though the stock is still meaningfully below its all-time high and consensus price targets sit below the current price — an unusual divergence worth watching into earnings. Oracle is trading near its 52-week low, making that level an important line in the sand: a decisive break below $132 would be a bearish technical signal, while holding it and reclaiming the mid-$150s to $160s would support the case that the selloff was overdone relative to the backlog and guidance. CoreWeave is the choppiest of the three, with extreme volatility (a beta near 2.9) that makes clean technical reads difficult — the stock has already staged sharp bounces off its lows on positive analyst notes, but sustained recovery likely depends on whether the Meta competitive threat proves to be more narrative than near-term revenue hit, something that should become clearer around CoreWeave’s August 18 earnings report.
Intel, Oracle and CoreWeave Are All Selling Off — Can These AI Stocks Recover? Bottom Line
All three stocks retain bullish analyst coverage and price targets above current levels, and none of the recent selloffs appear to be driven by a collapse in AI infrastructure demand itself. That said, each carries distinct, real risks: Intel’s re-rating may be ahead of its fundamentals, Oracle’s cash-flow and customer-concentration concerns are legitimate credit questions rather than just noise, and CoreWeave’s leverage and litigation overhang could take time to resolve. Whether these stocks recover — and how quickly — will likely hinge on the next round of earnings (Intel on July 23, CoreWeave on August 18, and Oracle’s fiscal Q1 2027 report later this year) confirming that backlog and guidance remain intact. For ongoing coverage, visit our Stock Fact Sheets hub, including our Nvidia (NVDA) fact sheet for broader context on the AI infrastructure trade, and our recent piece on this week’s bank earnings for the other major theme moving markets right now.
For informational purposes only. This article does not constitute investment advice. These are volatile, high-beta stocks; always do your own research and consider your own risk tolerance before making investment decisions.
About the Author
